Previous Close | 134.60 |
Open | 134.60 |
Bid | 120.75 |
Ask | 123.35 |
Strike | 185.00 |
Expire Date | 2024-06-21 |
Day's Range | 134.60 - 134.60 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Data from a late-stage study shows that treatment with Amgen's (AMGN) Uplizna achieves a statistically significant reduction in the risk of flares in patients with IgG4-RD, a rare disease.
Intra-Cellular (ITCI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.